It has to be the αv: Myofibroblast integrins activate latent TGF-β1

Nature Medicine

Volumn 19, Issue 12, 2013, Pages 1567-1568

  Hinz, Boris ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD51 ANTIGEN;

ANIMAL; FEMALE; GENETICS; KIDNEY; KIDNEY DISEASE; LIVER CIRRHOSIS; LUNG FIBROSIS; MALE; METABOLISM; NOTE; PATHOLOGY;

ANIMALS; FEMALE; INTEGRIN ALPHAV; KIDNEY; KIDNEY DISEASES; LIVER CIRRHOSIS; MALE; PULMONARY FIBROSIS;

EID: 84894635703     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm.3421     Document Type: Article

References (15)

1. Wynn, T.A. & Ramalingam, T.R. Nat. Med. 18, 1028–1040 (2012).
2. Hinz, B. et al. Am. J. Pathol. 180, 1340–1355 (2012).
3. Akhurst, R.J. & Hata, A. Nat. Rev. Drug Discov. 11, 790–811 (2012).
4. Kisseleva, T. et al. Proc. Natl. Acad. Sci. USA 109, 9448–9453 (2012).
5. Henderson, N.C. et al. Nat. Med. 19, 1617–1624 (2014).
6. Mederacke et al. Nat. Commun. 4, 2823 doi:10.1038/ncomms3823 (2013).
7. Robertson, I.B. & Rifkin, D.B. Cytokine Growth Factor Rev. 24, 355–372 (2013).
8. Munger, J.S. et al. Cell 96, 319–328 (1999).
9. Horan, G.S. et al. Am. J. Respir. Crit. Care Med. 177, 56–65 (2008).
10. Mu, D. et al. J. Cell Biol. 157, 493–507 (2002).
11. Shi, M. et al. Nature 474, 343–349 (2011).
12. Buscemi, L. et al. Curr. Biol. 21, 2046–2054 (2011).
13. Vogel, B.E., Tarone, G., Giancotti, F.G., Gailit, J. & Ruoslahti, E. J. Biol. Chem. 265, 5934–5937 (1990).
14. Munger, J.S., Harpel, J.G., Giancotti, F.G. & Rifkin, D.B. Mol. Biol. Cell 9, 2627–2638 (1998).
15. Desgrosellier, J.S. & Cheresh, D.A. Nat. Rev. Cancer 10, 9–22 (2010).